Correlation between Cytokine and Chemokine levels and Clinical Severity in Children with Mycoplasma pneumoniae Pneumonia
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The aim of this study was to evaluate the relationships between cytokine and chemokine levels and the clinical severity of Mycoplasma pneumoniae pneumonia. Methods: A retrospective analysis of clinical and laboratory parameters were performed. Serum levels of interleukin (IL)-6, IL-8, IL-10, IL-18, interferon-γ-inducible protein-10 (IP-10), macrophage inflammatory protein-1β, and tumor necrosis factor-α were measured. The severity of patients' clinical course and radiologic findings were also assessed. Results: Seventy-two patients (35 males and 37 females) with a median age of 3.9 years (range, 1–16 years) were enrolled. Patients with lobar pneumonia (n=29) had significantly higher C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and IL-18 values than those with broncho-interstitial pneumonia (n=43). However, the cytokine and chemokine values did not differ between the group that was treated with corticosteroids (n=31) and the one that was not (n=41). The CRP, ESR, lactate dehydrogenase (LDH), IL-18, and IP-10 values showed positive correlations with fever duration prior to admission. The CRP and ESR values were positively correlated with IL-18, and LDH, with IP-10 levels. Conclusions: CRP, ESR, LDH, IL-18, and IP-10 values were associated with the severity of the disease, manifesting lobar pneumonia or prolonged fever duration prior to admission.
Abstract
Purpose: The aim of this study was to evaluate the relationships between cytokine and chemokine levels and the clinical severity of Mycoplasma pneumoniae pneumonia. Methods: A retrospective analysis of clinical and laboratory parameters were performed. Serum levels of interleukin (IL)-6, IL-8, IL-10, IL-18, interferon-γ-inducible protein-10 (IP-10), macrophage inflammatory protein-1β, and tumor necrosis factor-α were measured. The severity of patients' clinical course and radiologic findings were also assessed. Results: Seventy-two patients (35 males and 37 females) with a median age of 3.9 years (range, 1–16 years) were enrolled. Patients with lobar pneumonia (n=29) had significantly higher C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and IL-18 values than those with broncho-interstitial pneumonia (n=43). However, the cytokine and chemokine values did not differ between the group that was treated with corticosteroids (n=31) and the one that was not (n=41). The CRP, ESR, lactate dehydrogenase (LDH), IL-18, and IP-10 values showed positive correlations with fever duration prior to admission. The CRP and ESR values were positively correlated with IL-18, and LDH, with IP-10 levels. Conclusions: CRP, ESR, LDH, IL-18, and IP-10 values were associated with the severity of the disease, manifesting lobar pneumonia or prolonged fever duration prior to admission.
참고문헌 (24)
- Yang J, "Cytokines in Mycoplasma pneumoniae infections", Cytokine Growth Factor Rev, 15, pp.157~168 (2004)
- Waites KB, "Mycoplasma pneumoniae and its role as a human pathogen", Clin Microbiol Rev, 17, pp.697~728 (2004)
- You-Sook Youn, "Mycoplasma pneumoniae pneumonia in children", Clinical and Experimental Pediatrics, 55(2), pp.42~47 (2012), 대한소아청소년과학회
- Akira S, "The role of IL-18 in innate immunity", Curr Opin Immunol, 12, pp.59~63 (2000)
- Dinarello CA, "Interleukin-18", Methods, 19, pp.121~132 (1999)
- Chung HL, "The relationship between serum endothelin (ET)-1 and wheezing status in the children with Mycoplasma pneumoniae pneumonia", Pediatr Allergy Immunol, 17, pp.285~290 (2006)
- Oishi T, "Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumonia", J Infect Chemother, 17, pp.803~806 (2011)
- Inamura N, "Management of refractory Mycoplasma pneumoniae pneumonia: utility of measuring serum lactate dehydrogenase level", J Infect Chemother, 20, pp.270~273 (2014)
- Bonecchi R, "Chemokines and chemokine receptors: an overview", Front Biosci (Landmark Ed), 14, pp.540~551 (2009)
- Bradley JS, "The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America", Clin Infect Dis, 53, pp.e25~76 (2011)
- Haugen J, "Cytokine concentrations in plasma from children with severe and non-severe community acquired pneumonia", PLoS One, 10, pp.e0138978~ (2015)
- Paats MS, "Local and systemic cytokine profiles in nonsevere and severe community-acquired pneumonia", Eur Respir J, 41, pp.1378~1385 (2013)
- Stuyt RJ, "Role of interleukin-18 in host defense against disseminated Candida albicans infection", Infect Immun, 70, pp.3284~3286 (2002)
- Lauw FN, "IL-18 improves the early antimicrobial host response to pneumococcal pneumonia", J Immunol, 168, pp.372~378 (2002)
- Narita M, "Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon", Clin Diagn Lab Immunol, 7, pp.909~914 (2000)
- Tanaka H, "Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults", Chest, 121, pp.1493~1497 (2002)
- Narita M, "Significant role of interleukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection", Clin Diagn Lab Immunol, 8, pp.1028~1030 (2001)
- Chmura K, "Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells", Am J Physiol Lung Cell Mol Physiol, 295, pp.L220~230 (2008)
- Miyashita N, "Setting a standard for the initiation of steroid therapy in refractory or severe Mycoplasma pneumoniae pneumonia in adolescents and adults", J Infect Chemother, 21, pp.153~160 (2015)
- Wang M, "Clinical and laboratory profiles of refractory Mycoplasma pneumoniae pneumonia in children", Int J Infect Dis, 29, pp.18~23 (2014)
- Zhang Y, "The clinical characteristics and predictors of refractory Mycoplasma pneumoniae pneumonia in children", PLoS One, 11, pp.e0156465~ (2016)
- Matsuda K, "Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka", Japan. BMC Infect Dis, 13, pp.591~ (2013)
- 양은애, "Additional corticosteroids or alternative antibiotics for the treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia", Clinical and Experimental Pediatrics, 60(8), pp.245~247 (2017), 대한소아청소년과학회
- Lu A, "Lactate dehydrogenase as a biomarker for prediction of refractory Mycoplasma pneumoniae pneumonia in children", Respir Care, 60, pp.1469~1475 (2015)